May 24, 2000Mintezol(r) Chewable Tablets
Point, PA (SafetyAlerts) - The Food
and Drug Administration (FDA) today reported that Merck and Company is conducting a recall
of Mintezol(r) Chewable (Thiabendazole) Tablets, USP, 500 mg, in unit dose packages of 36
tablets, because an unapproved binding agent was used in formulation.
The recalled Mintezol is a
prescription used for the treatment of parasitic infections and bears one of the following
Lot Numbers and EXP Dates:
J800 EXP Jan 04, J8001 EXP Jan 04, J8002 EXP Jan 04, J8003 EXP Jan 04, J8004 EXP Jan 04,
J8005 EXP Jan 04, J8011 EXP Feb 04, J8012 EXP Feb 04, J8013 EXP Mar 04, J8014 EXP Feb 04,
J8016 EXP Feb 04, J8017 EXP Feb 04.
FDA stated in its report that 24,163
units were distributed nationwide and internationally.
This ongoing Class II recall
was initiated by the company, by letter dated March 20, 2000. This is the first
public notice issued by the FDA.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-352-0
Notice of this product warning was
sent via email to SafeMail
subscribers May 24, 2000.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.